Vanguard Capital Opportunity Inv
(VHCOX)
41.15
-0.45
-1.08%
-0.45
-1.08%
MORE ON VHCOX
DETAILS
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 41.60 |
| Category | Large Growth |
| Net Assets | 2.68 Bil |
| Yield | 0.91% |
| Morningstar Risk | Above Average |
| Morningstar Return | Above Average |
- Last NAV update 6/19/2013 6:37 PM ET
INVESTMENT OBJECTIVE
| NA |
|---|
| The investment seeks long-term capital appreciation. The fund invests mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. It does not focus on companies of any particular size. The fund's investment advisor uses fundamental research to identify stocks that are expected to outperform the market over a three- to five-year time horizon and that are available at attractive prices relative to their fundamental values. |
CUMULATIVE PERFORMANCE OF $10,000
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 48.91% | 11.06% | -6.18% | 18.37% | 23.74% |
| Value ($) | 14,891.12 | 16,537.79 | 15,515.00 | 18,364.76 | 22,723.80 |
- Year to date performance as of 6/18/2013 12:00 AM ET
MANAGEMENT & PURCHASE INFO
| Symbol | Value ($) |
|---|---|
| Fund Family | Vanguard |
| Fund Manager | Theo Kolokotrones |
| Tenure (Years) | 15 |
| Fund Status | Open |
| Minimum Initial Purchase | 3,000.00 |
| Minimum IRA Investment | 3,000.00 |
| Front Load | 0.00 |
| Expense Ratio | 0.48% |
PERFORMANCE
| Symbol | Value ($) |
|---|---|
| 1 Month | -0.72% |
| 3 Months | 9.01% |
| 1 Year | 39.74% |
| 3 Years* | 16.09% |
| 5 Years* | 7.14% |
- * Annualized returns
- Performance as of 6/18/2013 12:00 AM ET
PEER COMPARISON
| VHCOX | Large Growth | |
|---|---|---|
| 5-Yr Return | 7.14% | 5.19% |
| Sharpe Ratio | 0.96 | 2.86 |
| Net Assets | 2.68 Bil | 631.34 Mil |
| Avg Market Cap | 22.55 Bil | 45.32 Bil |
| Avg P/E | 18.25 | 19.88 |
| Portfolio Turnover | 9 | 58 |
HOLDINGS
| Symbol | Value ($) |
|---|---|
| Stocks | 97.11% |
| Cash | 2.89% |
| Fixed Income | 0.00% |
| Other | 0.00% |
TOP 10 HOLDINGS
| NAME | % NET ASSETS |
|---|---|
| Biogen Idec Inc | 6.26% |
| Amgen Inc | 6.02% |
| Eli Lilly and Company | 4.47% |
| Roche Holding AG | 4.20% |
| Biomarin Pharmaceutical, Inc. | 3.41% |
| FedEx Corporation | 3.12% |
| Google, Inc. Class A | 2.84% |
| Monsanto Company | 2.78% |
| Novartis AG ADR | 2.57% |
| Medtronic, Inc. | 2.55% |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
RECENT QUOTES
WATCHLIST
You're not signed in
You’re not signed in to MSN Money, so you’re seeing the Watchlist that is tied to your computer. For a more consistent Watchlist experience, sign in to MSN Money.
Learn more
Sponsored by:
MARKET UPDATE
[BRIEFING.COM] Equities ended on their lows with the S&P 500 down 1.4%. The S&P entered today's session with a week-to-date gain of 1.5% as investors expected reassuring words from today's Federal Open Market Committee Statement. Stocks traded with s
...
More
MORE MARKET NEWS
Sponsored by:
INVESTING TIPS AND TOOLS